Instructions on How to Receive Credit
- Participants must review the materials on accreditation information, target audience, learning objectives, and disclosure information.
- Complete the entire activity, pre/post-test and evaluation.
- After passing the post-test, print out your electronic CE certificate.
- In order to successfully complete this activity learners must achieve a minimum of 70% on the post-test.
This activity is supported by unrestricted educational grants from Bristol-Myers Squibb, Genentech, Inc., UCB, AbbVie, Inc., & Amgen.
This activity is sponsored by the Institute for Continuing Healthcare Education
Release Date: June 14, 2013
Expiration Date: June 14, 2014
The Institute for Continuing Healthcare Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Institute for Continuing Healthcare Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The Institute for Continuing Healthcare Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity offers 0.75 contact hours to participating nurses. This credit may be applied toward licensure requirements in those states that recognize American Nurses Credentialing Center's Commission on Accreditation (ANCC-COA) accredited providers.
Accreditation applies solely to educational activities and does not imply approval or endorsement of any commercial product by the ANCC-COA.
The Institute for Continuing Healthcare Education is approved by the California Board of Registered Nursing, Provider Number 13313. The Institute for Continuing Healthcare Education approves this activity for 1.0 contact hours.
Relationships are abbreviated as follows: E, Educational Planning Committee; G, Grant/research support recipient; A, Advisor/review panel member/educational planning committee; C, Consultant/Independent Contractor; SS, Stock shareholder; SB, Speaker bureau; PE, Promotional Event Talks; H, Honoraria; O, Other.
Neil Birnbaum, MD, has disclosed the following relevant financial relationships in the past 12 months: Janssen, Amgen, Pfizer,& Abbott/PE.
Vivian Bykerk, MD, has disclosed the following relevant financial relationships that have occurred within the past 12 months: Amgen, Antares, Astellas, BMS, Genentech, Merck, and UCB/A, Novartis,/SS.
Jacqueline Fritz, RN, MSN, CNS, has disclosed the following relevant financial relationships that have occurred within the past 12 months: UCB, Novartis, Genentech, Amgen, Pfizer, Savient/SB.
Anne Jacobson, MPH, CCMEP, Medical Writer, has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.
Stanford Peng, MD, has disclosed that he does not have any relevant financial relationships specific to the subject matter of the content of this activity.
Activity Development and Management Team
Cathy Pagano, CCMEP; Allison A. Muller, Pharm.D, D.ABAT; Scott Kober, MBA, CCMEP; April Reynolds, MS, ELS; Sandra Davidson; and Megan Small are employees of the Institute and have no relationships to disclose.
Off-label Product Disclosure
This educational activity includes discussion of published and/or investigational uses of agents that are not indicated by the U.S. Food and Drug Administration. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
COURSE VIEWING REQUIREMENTS
Google Chrome 18.0+ for Windows, Mac, or Linux
Internet Explorer 8.0+ for Windows
Firefox 13.0+ for Windows, Mac, or Linux
Safari 4.0+ for Mac
For additional technical support, please send an email to firstname.lastname@example.org General Disclosure and Copyright Statement
The opinions expressed in this publication are those of the participating faculty and not those of the Institute for Continuing Healthcare Education (the Institute), Bristol-Myers Squibb, Genentech, AbbVie, UCB and Amgen or any manufacturers of products mentioned herein.
This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a healthcare professional regarding diagnostic and treatment options of a specific patient's medical condition. In no event will the Institute be responsible for any decision made or action taken based upon the information provided in this activity.
Participants are encouraged to consult the package insert for all products for updated information and changes regarding indications, dosages, and contraindications. This recommendation is particularly important for new or infrequently used products.
Copyright 2013. Institute for Continuing Healthcare Education (the Institute). All rights reserved. No part of this publication may be reproduced or transmitted in any other form or by any means electronic or mechanical—without first obtaining written permission from the Institute.
The Institute reserves the right to cancel or modify the activity content, faculty, and activities if necessary.